Beruflich Dokumente
Kultur Dokumente
PART- II:
3.
Functions.
5.
6.
7.
Fees.
8.
Signature of certificates.
PART-IV:
21.
Definitions.
22.
Delegation of powers.
23.
Import licences.
24.
26.
27.
28-A
29.
29.A
30.
30.A
Omitted.
30-AA
30-B
31.
32.
32.A
33.
33.A
34.
34.A
35.
35.A
36.
37.
38.
39.
40.
41.
42.
Omitted.
43.
43.A
43.B
PART-V:
44.
45.
46.
47.
48.
Fee.
49.
Qualifications of inspectors.
Controlling authority.
52.
53.
54.
55.
Form of receipts for seized during, cosmetic, record register documents or any other
material objects .
56.
56.A Form of receipt for samples of drugs where fair price tendered is refused.
57.
58.
PART-VI:
59.
Licensing autorities.
60.
Delegation of powers.
61.
62.
Duration of license.
63.
Duration of license.
64.
Conditions to be satisfied before a licence in form 20, 20-B, 20-F, 20-G, 21 or 21-B is
granted or renewed .
65.
Conditions of licences.
66.
Omitted.
PART -I : ( PRELIMINARY)
1. SHORT TITLE, EXTENT & COMMENCEMENT:
These Rules may be called the Drugs and Cosmetics Rules, 1945.
They extend to the whole of India.
2. DEFINITIONS:
1. The Act means the Drugs and Cosmetics Act, 1940 as amended from time to time.
2. Central Licence Approving Authority means the Drugs Controller of India,
appointed by the Central Government.
3. Director means the Director of the Central Drugs Laboratory;
4. From means a form set forth in Schedule A;
5. Homoeopathic medicines include any drug which is recorded in
homoeopathic proving or therapeutic efficacy of which has been established
through long clinical experience as recorded in authoritative homoeopathic
literature of India and abroad and which is prepared according to the techniques of
homoeopathic pharmacy and covers combination of ingredients of such
homoeopathic medicines but does not include a medicine which is administered by
parenteral route.
6.Laboratory means the Central Drugs Laboratory
7.Registered Homeopathic medical practitioner means a person who is registered
in the Central Register or State Register of Homeopathy.
8. Registered medical practitioner means a person
(i)Holding a qualification granted by an authority specified or notified under
Section 3 of the Indian Medical Degrees Act, 1916 .
(ii) Registered or eligible for registration in the register of dentists for a State under
the Dentists Act, 1948.
5
(iii) Who is engaged in the practice of veterinary medicine and who possesses
qualification approved by the State Government.
9. Retail sale means a sale whether to a hospital, or dispensary, or a medical,
educational or research institute or to any other person other than a sale by way of
wholesale dealing.
10.Sale by way of wholesale dealing means sale to a person for the purpose of selling
again and includes sale to a hospital, dispensary, medical, educational or research
institution.
11. Schedule means a Schedule to these Rules.
12. Poisonous substance means a substance specified in Schedule E.
22.The licensing authority with the approval of the Central Government by an order in
writing delegate the power to sign licences and Registration Certificate and such other powers
may be specified to any other person under his control.
23. An import licence in Form 10 shall be required for the import of drugs, excluding those
specified in Schedule X, and an import licence in Form 10 A shall be required
for the import of drugs specified in Schedule X.
24 (1) An application for an import licence shall be made to the licensing authority in Form 8 for
drugs excluding those specified in Schedule X, and in Form 8-A for drugs specified in
ScheduleX.
It shall be accompanied by a licence fee of one hundred rupees for a single drug and an
additional fee at the rate of one thousand rupees for each additional drug and by an
undertaking in Form 9 duly signed by or on behalf of the manufacturer:
A fee of two hundred and fifty rupees shall be paid for a duplicate copy of the licence
issued under this rule, if the original is defaced, damaged or lost.
25. A single application may be made, and a single licence may be issued, in respect of the
import of more than one drug or class of drugs manufactured by the same manufacturer:
Provided further that if a single manufacturer has two or more factories situated in
different places manufacturing the same or different drugs a separate licence shall be
required in respect of the drugs manufactured by each such factory.
26. An import licence shall be subject to the following conditions:
(i) The manufacturer at all times should observe the undertaking given by him or on his behalf.
(ii) The license shall allow any inspector authorized by the licensing authority to enter with or
without notice ,to any premises where the imported substance is stocked if any, employed for
testing the substance and to take samples.
(iii) The licensee shall maintain a record of all sales , showing particulars of the substance and of
the person to whom the sales were sold and such further particulars, if any, and such record shall
be open to the inspection of any inspector authorised in that behalf by the licensing authority;
Provided that in respect of the sale or distribution of drugs specified in Schedule X, the
licensee shall maintain separate record or register showing the following particulars, namely;
1. Name of the Drug.
7
2. Batch number.
3. Name and address of the manufacturer.
4. Date of transaction.
5. Opening stock on the business day.
6. Quantity of drug received, if any, and the source from which received.
7. Name of the purchaser, his address and licence number.
8. Balance quantity of drug at the end of the business day.
9. Signature of the person under whose supervision the drugs have been supplied.
27.On receipt of an application for an import licence in the form and manner prescribed in Rule
24, the licensing authority shall, on being satisfied that, if granted, the conditions of the licence
will be observed, issue an import licence in Form 10.
28 A licence unless, it is sooner suspended or cancelled, shall be valid for a period of three years
from the date of its issue. Provided that if application for a fresh licence is made three months
before the expiry of the existing licence the current licence shall be deemed to continue in force
until orders are passed on the application.
29. If the manufacturer fails to comply with any of the conditions of an import licence, the
licensing authority may give the manufacturer an opportunity to show cause, and explain why
such an order should not be passed, suspend or cancel it for such period as it thinks fit.
30. No biological or other special product specified in Schedule C or C (1) shall be imported
after the date shown on the label, wrapper or container of the drug as the date up to prevent
further complications.
31. No drug shall be imported unless it complies with the standard of strength, quality and purity,
if any, and the test prescribed in the rules shall be applicable for determining whether any such
imported drug complies with the said standard:
Provided further that the licensing authority shall not allow the import of any drug having
less than sixty percent residual shelf-life period as on the date of import:
32 No drug shall be imported unless it is packed and labeled in conformity with the rules in Parts
IX and X and further confirm to the standards laid down in Part XII .
33. Small quantities of drug is used for test or analysis to the following conditions:__
a) The licensee shall allow any inspector authorized by the licensing authority in this
8
behalf to enter, with or without prior notice, the premises where the substances are
kept, and to inspect the premises, and investigate the manner in which the substance
are being used and to take samples thereof.
b)The licensee shall keep a record and report to the licensing authority, the substances imported
under the licence, together with the quantities imported, the date of importation and the name of
the manufacturer.
34. (1) An application for a licence for examination, test or analysis shall be made in Form 12
and shall be made or countersigned by the head of the institution in which, or by a proprietor or
director or the company or firm by which the examination, test or analysis will be conducted.
(2) Every application in Form 12 shall be accompanied by a fee of one hundred rupees for a
single drug and an additional fee of fifty rupees or each additional drug.
(3) The fees shall be paid through a challan in the Bank of Baroda, Kasturba Gandhi Marg,
New Delhi or any other branch or branches of Bank of Baroda.
35. (1) A licence for examination, test or analysis may be cancelled by the licensing authority if
the manufacturer doesnt follow any of the conditions subject to which the licence was issued.
(2) A licensee whose licence has been cancelled may appeal to the Central Government
within three months of the date .
36. Small quantities of drugs, the import of which is otherwise prohibited under Section 10 of the
Act, may be imported for personal use subject to the following conditions:
(i) The drugs shall form part of a passengers bona fide baggage and shall be the
property of, and be intended for, the exclusive personal use of the passenger;
(ii) The drugs shall be declared to the Customs authorities if they so direct;
(iii) The quantity of any single drug so imported shall not exceed one hundred average
doses :Provided that the licensing authority may in an exceptional case in any individual case
sanction the import of a large quantity:
Provided further that any drug, imported for personal use but not forming part of bona fide
personal baggage, may be allowed to be imported subject to the following conditions, namely:-(i)the licensing authority, on an application made to it in Form 12-A is satisfied that the
drug is for bona fide personal use;
(ii)the quantity to be imported is reasonable in the opinion of the licensing authority and
9
sell, stock, exhibit or offer for sale or distribute] drugs, other than those included in Schedule X,
or for a licence [ to sell, stock, exhibit or offer for sale or distribute] drugs, included in Schedule
X, if the original is defaced, damaged or lost; Provided that in the case of itinerant vendor or an
applicant who desires to established a shop in a village or town having a population of 5,000 or
less, the fee for a duplicate copy of a licence if the original is defaced, damaged or lost, shall be
rupees two.
(4) Application for renewal of a licence [to sell, stock, exhibit or offer for sale or distribute]
drugs, after its expiry but within six months of such expiry [shall be accompanied by a fee of
rupees one thousand and five hundred plus an additional fee at the rate of rupees five hundred
per month or part thereof in Form 19, rupees five hundred plus an additional fee at the rate of
rupees two hundred fifty per month or part thereof in Form 19-A and rupees five hundred plus an
additional fee at the rate of rupees two hundred and fifty per month or part thereof in Form 19C:]
Provided that in the case of an itinerant vendor or an applicant desiring to open a shop in a
village or town having a population of 5,000 or less the application for such renewal shall be
accompanied by a fee of rupees ten, plus an additional fee at the rate of rupees eight per month
or part thereof.
60. A licensing authority with the approval of the State Government by an order in
writing delegate the power to sign licences and such other powers as may be specified in the
order to any other person under his control.
61. (1) A licence to sell, stock, exhibit or offer for sale or distribute drugs other than those
specified in Schedule C, C (1) and X by retail on restricted licence or by wholesale, shall be
issued in Form 20, Form 20-A or Form 20 B, as the case may be:
Provided that a licence in Form 20-A shall be valid for only such drugs as are specified in
the licence.
(2) A licence to sell, stock, exhibit or offer for sale or distribute drugs specified in Schedule C
and C (1) excluding those specified in Schedule X, by retail on restricted licence or by wholesale
shall be issued in Form 21, Form 21-A or Form 21-B, as the case may be.
Provided that a licence in Form 21-A shall not be granted for drugs specified in Schedule C
and shall be valid for only such Schedule C (1) drugs as are specified in the licence.
(3)A licence to sell, stock, exhibit or offer for sale or distribute drugs specified in Schedule
11
X by retail or by wholesale shall be issued in Form 20-F or Form 20-G as the case may be.
62. If drugs are sold or stocked for sale at more than one place, separate application shall be
made, and a separate licence shall be issued, in respect of each such place.
Provided that this shall not apply to vendors who have no specified place of business and
who will be licensed to conduct business in a particular area within the jurisdiction of the
licensing authority
63. An original licence or a renewed licence to sell drugs is valid for a period of five years
Provided that if the application for renewal of licence in force is made before its expiry or
if the application is made within six months after its expiry, after payment of additional fee, the
licence shall continue to be in force until orders are passed on the application.
The licence shall be deemed to have expired if application for its renewal is not made within six
months after its expiry.
64. (1)A licence to sell, stock, exhibit or offer for sale or distribute drugs shall not be granted or
renewed to any person unless the authority is satisfied that the premise in respect of which the
licence is to be granted or renewed are adequate, equipped with proper storage accommodation
for preserving the properties of the drugs and is in charge of a person to supervise and control the
sale, distribution and preservation of drugs .
Provided that in the case of a pharmacy a licence in Form 20 or 21 shall not be granted or
renewed unless the licensing authority is satisfied that the requirements prescribed for a
pharmacy in Schedule N have been complied with.
65.(1) Any drug shall, if compounded or made on the licenses premises should be compounded
or made under the direct and personal supervision of a registered Pharmacist.
(2) (1) The supply of any drug other than those specified in Schedule X on a prescription
of a Registered Medical Practitioner shall be recorded at the time of supply in a prescription
register specially maintained for the purpose and the serial number of the entry in the register
shall be entered on the prescription. The following particulars shall be entered in the register: _
(a) Serial number of the entry,
(b) The date of supply,
(c) The name and address of the prescriber,
(d) The name and address of the patient, or the name and address of the owner of
12
Any drugs supplied against prescription under the Employees State Insurance Scheme
(ii) Any drug other than that specified in Schedule C or Schedule H if it is supplied
in the original unopened container of the manufacturer and if the prescription is
duly stamped at the time of supply with the name of the supplier and the date on
which the supply was made and on condition that the provisions of sub rule (4)
(3) Of this rule are complied with (2) The option to maintain a prescription register or a cash or
credit memo book in respect of drugs and medicines which are supplied from or in the original
container, shall be made in writing to the Licensing Authority at the time of application for the
grant or renewal of the licence to sell by retail.
Provided that the Licensing Authority may require records to be maintained only in
prescription register if it is satisfied that the entries in the carbon copy of the cash or credit memo
book are not legible. The supply by retail, otherwise than on a prescription of a drug specified in
Schedule C shall be recorded at the time of supply either :
(i) In a register specially maintained for the purpose in which the following particulars shall
be entered :_
(a) Serial number of the entry,
13
14
REFERENCES:
S.W.DESHPANDE, WILESH GANDHI; Drug & Cosmetic act Rules 1945; Drug &
Cosmetic act 1940 & Rules 1945; 2009; 5th edition; pg.no: 99-143.
VIJAY MALIK; Drug & Cosmetic act Rules 1945, Law relating to drugs & cosmetics;
2007; 9th edition 71-169.
The Drugs and Cosmetics Act and Rules (PDF) (As amended up to the 30th june, 2005).
15